Medical School or Training
University of Miami Hospital, 1996
University of Michigan Health System, Surgery General, MI, 2003
University of Michigan Health System, Thoracic Surgery, MI, 2005
Surgical Critical Care, University of Michigan Health System, 2001
Surgical Critical Care
Dr. Haft's research interests are related to the creation, development, and application of mechanical devices for patients with advanced heart or lung failure. He has been involved in a project to engineer an implantable artificial lung capable of providing long term respiratory support for patients with advanced lung disease, ideally to serve as a bridge to heart transplantation. He is a co-investigator on a NIH funded bioengineering research partnership grant under the direction of Dr. Robert Bartlett. Their accomplishments have lead to a currently proposed multi-center clinical trial using extracorporeal circulation, termed Ambulatory Lung Assist, for decompensating patients currently awaiting lung transplantation. He has also initiated a research plan to develop a novel Ventricular Assist Device for the temporary support of patients in cardiogenic shock. The device, termed the BioVad, is being developed in conjunction with the local bioengineering firm Michigan Critical Care Consultants. He is also engaged in clinical research related to mechanical support of end stage heart failure and cardiogenic shock.
Dr. Jonathan W Haft joined the faculty in 2005 after completing his training in General Surgery, Critical Care, and Thoracic Surgery at the University of Michigan. He is the director of the Extracorporeal Life Support Program, replacing the legendary program founder, Dr. Robert Bartlett. His interests include the use of mechanical circulatory support for heart failure and shock, critical care, and heart transplantation. Additionally, he is the associate director of the Cardiovascular Intensive Care Unit at the University of Michigan Cardiovascular Center and he is the division chief of Cardiothoracic Surgery at the Ann Arbor Veterans Affairs Hospital.
Spurlock DJ, Ranney DN, Fracz E, Mazur DE, Bartlett RH, Haft JW. In vitro testing of a novel blood pump designed for temporary extracorporeal support. ASAIO J. 58(2):pp. 109-14. Mar-April 2012.
Spurlock DJ, Koch K, Mazur D, Fracz EM, Bartlett RH, Haft JW. Preliminary In Vivo Testing of a Novel Pump for Short-Term Extracorporeal Life Support. Ann Thorac Surg. Ann. Thorac. Surg., 93;141-146, January 2012.
Spurlock DJ, Toomasian JM, Romano MA, Cooley E, Bartlett RH, Haft JW. A Simple Technique to Prevent Limb Ischemia During Veno-Arterial ECMO Using The Femoral Artery: The Posterior Tibial Approach. Perfusion, 27(2): pp. 141-145, March 2012.
Chapters in Books
Bartlett RH, Haft JW. Chapter 32, Artificial Lungs. Advanced Therapy in Thoracic Surgery, Second Edition. Kenneth L. Franco, MD, Joe B. Putnam Jr., MD. Published by B.C. Decker Inc. pp. 398-406; 2005.
Haft JW, Bartlett RH. Extracorporeal Life Support for Respiratory Failure. Current Surgical Therapy, Ninth Edition. John L. Cameron, MD. Published by Mosby-Elsevier 2007.
Haft JW. Chapter 19, The Heart: I. Surgical Treatment of Acquired Cardiac Disease. Current Diagnosis and Treatment Surgery, Thirteenth Edition. Gerard M. Doherty, MD. Published by McGraw Hill Medical pp. 359-391; 2010.
Haft JW. Chapter 83, Ischemic Heart Disease. Greenfield’s Surgery Scientific Principles & Practice, Fifth Edition. Michael W. Mulholland, MD, Phd, Keith D. Lillemoe, MD, Gerard M. Doherty, MD, Ronald V. Maier, MD, Diane M. Simeone, MD, Gilbert R. Upchurch, Jr., MD. Published by Lippincott Williams & Wilkins pp. 1462-1482; 2011.
Haft JW. Artificial Lungs. Cardiothoracic Surgery Review. Vinod H. Thourani and Kenneth L. Franco. Published by Lippincott Williams & Wilkins;1 Edition, pp. 1249-12-53; 2012.
Haft JW, Firmin R. Adult Cardiac Support. ECMO Extracorporeal Cardiopulmonary Support in Critical Care 4th Edition, pp. 323-330; 2012.